Lusk G.: The Science of Nutrition. Saunders, Philadelphia, PA, 1928, p 145
5.
Szám I.: Introduction. IN Ammonia Metabolism, Szám I (ed). Schattauer, Stuttgart , 1972, pp 3-5
6.
Fürst P., Josephson B., Maschio G., et al: Nitrogen balance after intravenous and oral administration of ammonium salts to man. J Appl Physiol26:13-22, 1969
7.
Fürst P., Jonsson A., Josephson B., et al: Distribution in muscle and liver vein protein of 15N administered as ammonium acetate to man. J Appl Physiol29:307-312, 1970
8.
Fürst P., Bergström J., Josephson B., et al: The effect of dialysis and administration of essential amino acids on plasma and muscle protein synthesis studied with 15N in uremic patients . Proc Eur Dial Transplant Assoc6:175-181, 1970
9.
Fürst P.: 15N studies in severe renal failure. I. Influence of amino acid administration on nitrogen balance. Scand J Clin Lab Invest29:359-367, 1972
10.
Richards P. , Metcalfe-Gibson A., Ward EE, et al: Utilisation of ammonia nitrogen for protein synthesis in man, and the effect of protein restriction and uraemia . Lancet2:845-849, 1967
11.
Giordano C. , De PC, Balestrieri C., et al: Incorporation of urea 15N in amino acids of patients with chronic renal failure on low nitrogen diet. Am J Clin Nutr21:394-404, 1968
12.
Fürst P., Jonsson A.: Control and modification of methods for determination of 15N in biological material. Acta Chem Scand25:930-938, 1971
13.
Fürst P.: 15N-studies in severe renal failure. II. Evidence for the essentiality of histidine. Scand J Clin Lab Invest30:307-312, 1972
14.
Vinnars E., Fürst P., Josephson B.: Einwirkung des Verhältnisses zwischen essentiellen und nicht-essentiellen Aminosäuren auf die Stickstoff-Retention bei Gesunden. IN Anaesthesiologie und Wiederbelebung, Anonymous. Springer Verlag, Berlin, 1972, pp 9-10
15.
Elliott DF, Neuberger A.: The irreversibility of the deamination of threonine in the rabbit and rat . Biochem J46:207-210, 1950
16.
Alvestrand A., Ahlberg M., Bergström J., et al: Clinical results of long term treatment with a low protein diet and a new amino acid preparation in patients with chronic uremia. Clin Nephrol19:67-73, 1983
17.
Fürst P.: Amino acid metabolism in uremia. J Am Coll Nutr8:310-323, 1989
18.
Bergström J. : Amino acid abnormalities in renal failure . IN Nutrition and the Origin of Disease, Halstead C, Rucker R (eds). Academic Press, New York, 185-198, 1989
19.
Walser M., Lund P., Ruderman NB, et al: Synthesis of essential amino acids from their alpha-keto analogues by perfused rat liver and muscle. J Clin Invest52:2865-2877, 1973
20.
Richards P.: The metabolism and clinical relevance of the keto acid analogues of essential amino acids. Clin Sci Mol Med54:589-593, 1978
21.
Giordano C., Phillips ME, De SN, et al: Utilisation of ketoacid analogues of valine and phenylalanine in health and uraemia. Lancet1:178-182, 1972
22.
Halliday D., Madigan M., Chalmers RA, et al: The degree of conversion of alpha-keto acids to valine and phenylalanine in health and uraemia. Q J Med50:53-62, 1981
23.
Kedenburg C-P. : A lithium buffer system for accelerated single-column amino acid analysis in physiological fluids. Anal. Biochem.40:35-42, 1971
24.
Bergström J. , Fürst P., Noree L-O., et al: The effect of peritoneal dialysis on the intracellular free amino acids in muscle from uremic patients. Proc Eur Dial Transplant Assoc9:393-401, 1972
25.
Bergström J. , Fürst P., Noree L-O., et al: Intracellular free amino acid concentration in human muscle tissue. J Appl Physiol36:693-697, 1974
26.
Vinnars E., Bergström J., Fürst P.: Influence of the postoperative state on the intracellular free amino acids in human muscle tissue. Ann Surg182:665-671, 1975
27.
Graser TA, Godel HG, Albers S., et al: An ultra rapid and sensitive high-performance liquid chromatographic method for determination of tissue and plasma free amino acids. Anal Biochem151:142-152, 1985
28.
Fürst P.: Intracellular muscle free amino acids: Their measurement and function . Proc Nutr Soc42:451-462, 1983
Wretlind A. : Parenteral nutrition. Nutr Rev39:257-265, 1981
31.
Wilmore DW: The practice of clinical nutrition: How to prepare for the future . JPEN13:337-343, 1989
32.
Fürst P.: Old and new substrates in clinical nutrition. J Nutr128:789-796, 1998
33.
Annan GL: An exhibition of books on the growth of our knowledge of blood transfusion . Bull NY Acad Med15:622-632, 1939
34.
Abderhalden E., Rona P.: Fütterungsversuche mit durch Pankreatin, durch Pepsinsalzsäure plus Pankreatin und durch Säure hydrolysiertem Casein . Hoppe-Seyler's Z Physiol Chem42:528-539, 1904
35.
Friedrich PL : Die künstliche subkutane Ernährung in der praktischenChirugie Arch Klin Chir73:507-516, 1904
36.
Henriques V. , Andersen AC: Über parenterale Ernährung durch intravenöse Injektion. Hoppe-Seyler's Z Physiol Chem88 :357-369, 1913
37.
Elman R.: Amino acid content of the blood following intravenous injection of hydrolyzed casein. Proc Soc Exp Biol Med37 :437-440, 1937
38.
Wretlind A. : Free amino acids in dialyzed casein digest . Acta Physiol Scand13:45-54, 1945
39.
Wretlind A. : The amino acid content of a dialysed enzymatic casein hydrolysate. Acta Physiol Scand27:189-203, 1952
40.
Agar WT, Hird FJR, Sidhu GS: The active absorption of amino acids by the intestine. J Physiol145:255-263, 1953
41.
Wiggans DS, Johnston JM: The absorption of peptides. Biochim Biophys Acta32:69-73, 1959
42.
Newey H., Smyth DH: The intestinal absorption of some dipeptides. J Physiol145:48-56, 1959
43.
Matthews DM , Craft IL, Geddes DM, et al: Absorption of glycine and glycine peptides from the small intestine of the rat. Clin Sci35:415-424, 1968
44.
Adibi SA, Phillips E.: Evidence for greater absorption of amino acid from peptide than from free form by human intestine. Clin Res16:446, 1968
45.
Matthews DM : Intestinal absorption of peptides. Physiol Rev55:535-608, 1975
46.
Das M., Radhakrishnan AN: Role of peptidases and peptide transport in the intestinal absorption of proteins . World Rev Nutr Diet24:58-87, 1976
47.
Das M., Radhakrishnan AN: Glycyl-L-leucin hydrolase, a versatile 'master' dipeptidase from monkey small intestine. Biochem J135:609-615, 1973
48.
Stehle P., Kühne B., Kubin W., et al: Synthesis and characterization of tyrosine- and glutamine-containing peptides. J Appl Biochem4:280-286, 1982
Jakubke H-D. , Kuhl P.Könnecke A.: Basic principles ofproteasecatalyzed peptide bond formation. Angew Chem Int Ed24:85- 93, 1985
51.
Stehle P., Bahsitta H-P., Monter B. et al: Papain-catalyzed synthesis of dipeptides. A novel approach using free amino acids as nucleophiles. Enzyme Microb Technol12:56-60, 1990
52.
Monter B., Herzog B., Stehle P. et al: Kinetically controlled synthesis of dipeptides using ficin as biocatalyst. Biotechnol Appl Biochem14:183-191, 1991
53.
Stehle P., Bahsitta H-P., Fürst P.: Analytical control of enzyme-catalyzed peptide synthesis using capillary isotachophoresis . J Chromatogr370:131-138, 1986
54.
Fürst P., Pogan K., Hummel M., et al: Reappraisal of indispensable amino acids. Design of parenteral synthetic dipeptides for clinical nutrition: Synthesis and characterization . Ann Nutr Metab41:1-9, 1997
55.
Behal FJ, Hamilton RD, Dawson FB, et al: A study of the activity of human plasma aminopeptidase components on dipeptides and chromogenic substrates. Arch Biochem Biophys108:207-214, 1964
56.
Krzysik BA, Adibi SA: Cytoplasmic dipeptidase activities of kidney, ileum, jejunum, liver, muscle, and blood. Am J Physiol233:E450-456, 1977
57.
Adibi SA, Paleos GA, Morse EL: Influence of molecular structure on half-life and hydrolysis of dipeptides in plasma: Importance of glycine as N-terminal amino acid residue. Metabolism35:830-836, 1986
58.
Herzog B., Frey B., Pogan K., et al: In vitro peptidase activity of rat mucosa cell fractions against glutamine-containing dipeptides. J Nutr Biochem7:135-141, 1996
59.
Abumrad NN, Morse EL, Lochs H., et al: Possible sources of glutamine for parenteral nutrition: Impact on glutamine metabolism. Am J Physiol257:E228-234, 1989
60.
Stehle P., Fürst P.: In vitro hydrolysis of glutamine-, tyrosine-and cystine-containing short chain peptides. Clin Nutr9:37-38, 1990
61.
Hummel M., Pogan K., Stehle P., et al: Intestinal taurine availability from synthetic amino acid-taurine conjugates: An in vitro perfusion study in rats. Clin Nutr16:137-139, 1997
62.
Fürst P., Pogan K., Hummel M., et al: Design of parenteral synthetic dipeptides for clinical nutrition: In vitro and in vivo utilization. Ann Nutr Metab41:10-21, 1997
63.
Adibi SA, Krzysik BA, Drash AL: Metabolism of intravenously administered dipeptides in rats: Effects on amino acid pools, glucose concentration and insulin and glucagon secretion . Clin Sci Mol Med52:193-204, 1977
64.
Adibi SA, Krzysik BA: Effect of nephrectomy and enterectomy on plasma clearance of intravenously administered dipeptides in rats. Clin Sci Mol Med52:205-213, 1977
65.
Adibi SA, Morse EL: Enrichment of glycine pool in plasma and tissues by glycine, di-, tri-, and tetraglycine. Am J Physiol243:E413-417, 1982
66.
Daabees TT, Stegink LD: L-Alanyl-L-tyrosine as a tyrosine source during intravenous nutrition of the rat. J Nutr108: 1104-1113, 1978
67.
Stehle P., Albers S., Pollack L., et al: In vivo utilization of cystine-containing synthetic short chain peptides after intravenous bolus injection in the rat. J Nutr118:1470-1474, 1988
68.
Kee AJ, Smith RC, Gross AS, et al: The effect of dipeptide structure on dipeptide and amino acid clearance in rats. Metabolism43:1373-1378, 1994
69.
Neuhäuser M.Wandira JA, Göttmann U., et al: Utilization of N-acetyl-L-tyrosine and glycyl-L-tyrosine during long-term parenteral nutrition in the growing rat. Am J Clin Nutr42:585- 596, 1985
70.
Fürst P., Kuhn KSStehle P.: New nitrogen-containing substrates in artificial nutrition. IN From Nutritional Support to Pharmacologic Nutrition in the ICU , Kudsk KA.Pichard C (eds). Springer, Heidelberg . 2000. pp 449-460
71.
Stehle P., Weber S.Fürst P.: Parenteral glycyl-L-tyrosine maintains tyrosine pools and supports growth and nitrogen balance in phenylalanine-deficient rats. J Nutr126:663-667, 1996
72.
Hilton MA, Hilton FKMontgomery W., et al: Use of the stable peptide. gamma-L-glutamyl-L-tyrosine, as an intravenous source of tyrosine in mice. Metabolism40:634-638, 1991
73.
Radmacher PG , Hilton MA, Hilton FK, et al: Use of the soluble peptide 7-L-glutamyl-L-tyrosine to provide tyrosine in total parenteral nutrition (TPN) in rats. JPEN17:337-344, 1993
74.
Berger DC, Hilton MA, Hilton FK, et al: Intravenous gamma-glutamyl-tyrosine elevates brain tyrosine but not catecholamine concentrations in normal rats. Metabolism45:126-132, 1996
75.
Jiang Z.-M., Wang L.-J., Qi Y., et al: Comparison of parenteral nutrition supplemented with L-glutamine or glutamine dipeptides. JPEN17:134-141, 1993
76.
Lochs H., Williams PE, Morse EL, et al: Metabolism of dipeptides and their constituent amino acids by liver, gut, kidney, and muscle. Am J Physiol254:E588-594, 1988
77.
Stehle P., Ratz I., Fürst P.: Whole-body autoradiography in the rat after intravenous bolus injection of L-alanyl-L-[U-14 C]glutamine. Ann Nutr Metab35:213-220, 1991
78.
Babst R., Hörig H., Stehle P., et al: Glutamine peptide-supplemented long-term TPN: Effects on intracellular and extracellular amino acid patterns, nitrogen economy, and tissue morphology in growing rats. JPEN17:566-574, 1993
79.
Karner J., Roth E., Ollenschläger G., et al: Glutamine-containing dipeptides as infusion substrates in the septic state. Surgery106:893-900, 1989
80.
Roth E., Karner J., Ollenschldger G., et al: Alanylglutamine reduces muscle loss of alanine and glutamine in postoperative anaesthetized dogs. Clin Sci75:641-648, 1988
81.
Borel MJ, Williams PE, Jabbour K., et al: Chronic hypocaloric parenteral nutrition containing glutamine promotes hepatic rather than skeletal muscle or gut uptake of glutamine after fasting. JPEN20:25-30, 1996
82.
Bai M-J. , Jiang Z-M., Liu Y-W., et al: Effects of alanyl-glutamine on gut barrier function. Nutrition12:793-796, 1996
83.
Liu PT, Ionnides C., Symons AM, et al: Role of tissue glutathione in prevention of surgical trauma . Xenobiotica23:899-911, 1993
84.
Naka S., Saito H., Hashiguchi Y., et al: Alanyl-glutamine-supplemented TPN improves survival and protein metabolism in rat protracted peritonitis model. JPEN20:417-423, 1996
85.
Schröder J. , Wardelmann E., Winkler W., et al: Glutamine dipeptide-supplemented parenteral nutrition reverses gut atrophy, disaccharidase enzyme activity, and absorption in rats. JPEN19:502-506, 1995
86.
Tamada H., Nezu R., Imamura I., et al: The dipeptide alanylglutamine prevents intestinal mucosal atrophy in parenterally fed rats. JPEN16:110-116, 1992
87.
Tamada H., Nezu R., Matsuo Y., et al: Alanyl glutamine-enriched TPN restores intestinal adaptation after either proximal or distal massive resection in rats. JPEN17:236-242, 1993
88.
Scheppach W. , Dusel G., Kuhn T., et al: Effect of L-glutamine and n-butyrate on the restitution of rat colonic mucosa after acid induced injury. Gut38:878-885, 1996
89.
Li YS, Li JS, Jiang JW, et al: Glycyl-glutamine-enriched long-term TPN attenuates bacterial translocation following small bowel transplantation in the pig. J Surg Res82:106-111, 1999
90.
Wischmeyer PE, Musch MW, Madonna MB, et al: Glutamine protects intestinal epithelial cells: Role of inducible HSP70. Am J Physiol272:G879-884, 1997
91.
Li J., Kudsk KAJanu P. et al: Effect of glutamine-enriched TPN on small intestinal gut-associated lymphoid tissue and upper respiratory tract immunity. Surgery121:542-549. 1997
92.
Li J., King BKJanu PG et al: Glycyl-L-glutamine-enriched TPN maintains small intestine gut-associated lymphoid tissue and upper respiratory tract immunity. JPEN22:31-36. 1998
93.
Yu JC, Jiang ZM, Li DM et al: Alanyl-glutamine preserves hepatic glutathione stores after 5-FU treatment. Clin Nutr15:261-265. 1996
94.
Harward TRCoe D.Souba WW et al: Glutamine preserves gut glutathione levels during intestinal ischemia/reperfusion. J Surg Res56:351-355, 1994
95.
Hong RWRounds JD, Helton WS et al: Glutamine preserves liver glutathione after lethal hepatic injury . Ann Surg215:114- 119, 1992
96.
Albers S., Wernerman J., Stehle P., et al: Availability of amino acids supplied intravenously in healthy man as synthetic dipeptides : Kinetic evaluation of L-alanyl-L-glutamine and glycyl-L-tyrosine. Clin Sci75:463-468, 1988
97.
Druml W.Lochs H., Roth E., et al: Utilization of tyrosine dipeptides and acetyltyrosine in normal and uremic humans. Am J Physiol260:E280-285, 1991
98.
Albers S., Wernerman J., Stehle P., et al: Availability of amino acids supplied by constant intravenous infusion of synthetic dipeptides in healthy man. Clin Sci76:643-648, 1989
99.
Lochs H., Hübl W., Gasic S., et al: Glycylglutamine: Metabolism and effects on organ balances of amino acids in postabsorptive and starved subjects. Am J Physiol262:E155-160, 1992
100.
Lochs H., Roth E., Gasic S., et al: Splanchnic, renal, and muscle clearance of alanylglutamine in man and organ fluxes of alanine and glutamine when infused in free and peptide forms. Metabolism39:833-836, 1990
101.
Druml W.: Nutritional considerations in the treatment of acute renal failure in septic patients. Nephrol Dial Transplant9:S219-223, 1994
102.
Stehle P., Zander J., Mertes N., et al: Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery. Lanceti:231-233, 1989
103.
Druml W., Hübl W., Roth E., et al: Utilization of tyrosine-containing dipeptides and N-acetyl-tyrosine in hepatic failure. Hepatology21:923-928, 1995
104.
Fürst P.: The role of antioxidants in nutritional support. Proc Nutr Soc55:945-961, 1996
105.
Grimble RF : Nutritional antioxidants and the modulation of inflammation: Theory and practice. New Horizons2:175-185, 1994
106.
Fürst P., Stehle P.: Parenteral nutrition substrates. IN Artificial Nutrition Support in Clinical Practice, Payne-James J, Grimble G, Silk D (eds). Edward Arnold, London , 1995, pp 301-322
107.
Fürst P., Albers S., Stehle P., et al: Parenteral use of L-alanyl-L-glutamine (Ala-Gln) and glycyl-L-tyrosine (Gly-Tyr) in postoperative patients. Clin Nutr7:S41, 1988
108.
Jacobi CA, Ordeman J., Zuckermann H., et al: The influence of Alanyl-Glutamine in postoperative TPN on immune functions and morbidity: Preliminary results of a prospective randomized trial . Langenbecks Arch Chir1998:605-611, 1998
109.
Morlion BJ, Köller M., Wachtler P., et al: Influence of L-alanyl-L-glutamine (ala-gln) dipeptide on the synthesis of leukotrienes and cytokines in vitro. 4th International Congress on The Immune Consequences of Trauma, Shock and Sepsis, 1997, pp 269-272
110.
deBeaux AC , O'Riordain MG, Ross JA, et al: Glutamine-supplemented TPN reduces blood mononuclear cell interleukin-8 release in severe acute pancreatitis . Nutrition14:261-265, 1998
111.
Morlion BJ , Stehle P., Wachtler P., et al: TPN with glutamine dipeptide after major abdominal surgery: A randomized, double-blind, controlled study. Ann Surg227:302-308, 1998
112.
Morlion BJ , Torwesten E., Kuhn KS, et al: Cysteinyl-leucotriene generation as a biomarker for survival in the critically ill. Crit Care Med (in press)
113.
Häussinger D., Roth E., Lang F., et al: Cellular hydration state: An important determinant of protein catabolism in health and disease . Lancet341:1330-1332, 1993
114.
Borel MJ, Williams PE, Jabbour K., et al: Parenteral glutamine infusion alters insulin-mediated glucose metabolism. JPEN22:280-285, 1998
115.
Ballard TC , Farag A., Branum GD, et al: Effect of L-glutamine supplementation on impaired glucose regulation during intravenous lipid administration . Nutrition12:349-354, 1996
116.
Khogali SE , Harper AA, Lyall JA, et al: Effects of L-glutamine on post-ischaemic cardiac function: Protection and rescue. J Mol Cell Cardiol30:819-827, 1998
117.
Stehle P., Ratz I., Fürst P.: In vivo utilization of intravenously supplied L-alanyl-L-glutamine in various tissues of the rat. Nutrition5:411-415, 1989
118.
Liu YW , Bai MX, Ma YX et al: Effects of alanyl-glutamine on intestinal adaptation and bacterial translocation in rats after 60% intestinal resection . Clin Nutr16:75-78, 1997
119.
Hammarqvist F., Wernerman J.Von der Decken A., et al: Alanyl-glutamine counteracts the depletion of free glutamine and the postoperative decline in protein synthesis in skeletal muscle. Ann Surg212:637-644. 1990
120.
Karner J.Roth E.Stehle P., et al: Influence of glutamine-containing dipeptides on muscle amino acid metabolism. IN Nutrition in Clinical Practice, Hartig W, Dietze G, Weiner R, et al (eds). Karger, Basel, 1989, pp 56-70
Jiang ZM, Cao JD, Zhu XG, et al: The impact of glutamine dipeptide on nitrogen balance, intestinal permeability and clinical outcome of post operative patients. JPEN23:S52-58, 1999
123.
Fürst P.: Effects of supplemental parenteral L-aLanyl-L-glutamine (ALA-GLN) following elective operation: A European multicenter study. Clin Nutr (in press)
124.
Petersson B. , Waller S-O., Von der Decken A., et al: The long-term effect of postoperative TPN supplemented with glycylglutamine on protein synthesis in skeletal muscle. Clin Nutr10(special suppl 2):10, 1991
125.
Barua JM, Wilson E., Downie S., et al: The effect of alanylglutamine peptide supplementation on muscle protein synthesis in post-surgical patients receiving glutamine-free amino acids intravenously. Proc Nutr Soc51:104A. 1992
126.
Van der Hulst Rrwj.Van Kreel BKVon Meyenfeldt MF et al: Glutamine and the preservation of gut integrity. Lancet341: 1363-1365, 1993
127.
Decker-Baumann C., Frohmüller S. v.Herbay A., et al: Reduction of chemotherapy-induced side-effects by parenteral glutamine supplementation in patients with metatstatic colorectal cancer. Eur J Cancer35:202-207, 1999
128.
van Zaanen HCT , van der Lelie J., Timmer JG, et al: Parenteral glutamine supplementation does not ameliorate chemotherapy-induced toxicity . Cancer74:2879-2884, 1994
129.
Brown SA, Goringe A., Fegan C., et al: Parenteral glutamine protects hepatic function during bone marrow transplantation. Bone Marrow Transplant22:281-284, 1998
130.
O'Riordain MG, Fearon KC, Ross JA, et al: Glutamine-supplemented TPN enhances T-lymphocyte response in surgical patients undergoing colorectal resection . Ann Surg220:212- 221, 1994